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Abstract
Objective To elucidate the effects of antiepileptic drugs
(AEDs) on bone health status of ambulatory epileptic children.
Methods A total of 120 epileptic children aged 2–15 y were
enrolled in three groups. The first group was on therapy with
carbamazepine, phenobarbital or primidone. The second was
treated with valproic acid and the third group was untreated.
Serum calcium, phosphorous, total alkaline phosphatase, and
parathyroid hormone levels were compared between groups.
Bone mineral density tests were also performed at four sites of
the lumbar spine and three sites of femoral neck and results
were compared between the groups.
Results Of all enrolled subjects, 67 patients (55.8 %) were
vitamin D deficient. The three groups were not significantly
different in terms of vitamin D, calcium, phosphorus, total
alkaline phosphatase, and parathyroid hormone levels. While
patients in first group had lower Z-score of femoral neck and
lumbar spine compared to those on valproic acid, these values
were also significantly different than that of the third group.
Conclusions It can be concluded that both enzyme-inducing
AEDs and non enzyme-inducing AEDs decrease bone miner-
al density (BMD). Also alkaline phosphatase (ALP) is affect-
ed in ambulatory epileptic children on enzyme-inducing
AEDs. Nevertheless, valproic acid (a non-enzyme-inducing
agent) does not have the mentioned side effects.
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Introduction
About one percent of children worldwide suffer from various
types of epilepsy and usually require long-term treatment with
antiepileptic drugs (AEDs) [1]. The association of skeletal
abnormalities with chronic antiepileptic therapy was first de-
scribed about three decades ago and most of the available data
is from adults [2].
AEDs associated osteopathy includes decreased bone
mineral density (BMD), increased fracture risk, and overt
osteomalacia [2].
Although the skeletal consequences of antiepileptic drugs
may vary, the AEDs, especially enzyme-inducing drugs such
as phenobarbital, primidone, phenytoin, and carbamazepine
are generally known to alter bone metabolism [3, 4].
Subjects on enzyme-inducing AEDs are expected to have
lower BMD compared to those on non-enzyme-inducing
medicines such as valproic acid in which the hepatic cyto-
chrome P450 enzyme system remains intact [3, 4].
Unpleasant side effects of AEDs on calcium metabolism
and bone density were primarily reported in institutionalized
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